April 24, 2026 Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
April 24, 2026 A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
April 24, 2026 COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law Firm
